Basics Neumora Therapeutics, Inc. IPO Date: September 15, 2023 Sector: Healthcare Industry: Biotech Market Cap: $272.07M Activated in VL: True Average Daily Range Avg Daily Range: $0.30 | 3.66% Avg Daily Range (30 D): $0.07 | 4.18% Avg Daily Range (90 D): $0.06 | 4.75% Institutional Daily Volume Avg Daily Volume: .92M Avg Daily Volume (30 D): .85M Avg Daily Volume (90 D): .95M Trade Size Avg Trade Size (Sh.): 132 Avg Trade Size (Sh.) (30 D): 215 Avg Trade Size (Sh.) (90 D): 204 Institutional Trades Total Inst.Trades: 289 Avg Inst. Trade: $1.82M Avg Inst. Trade (30 D): $.54M Avg Inst. Trade (90 D): $1.8M Avg Inst. Trade Volume: .21M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.34M Avg Closing Trade (30 D): $5.12M Avg Closing Trade (90 D): $5.12M Avg Closing Volume: 292.74K     News Jul 23, 2025 @ 11:00 AM Neumora Therapeutics to Report Second Quarter 2025... Source: Helen Rubinstein Jul 9, 2025 @ 11:00 AM Neumora Therapeutics Announces Initiation of Phase... Source: Nick Brandon, Ph.D. May 28, 2025 @ 1:45 AM Kuehn Law Encourages Investors of Grocery Outlet H... Source: N/A May 28, 2025 @ 1:40 AM Kuehn Law Encourages Investors of Neumora Therapeu... Source: N/A Apr 6, 2025 @ 1:35 PM Faruqi & Faruqi Reminds Neumora Therapeutics Inves... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.33 $-.42 Diluted EPS $-.33 $-.42 Revenue $ $ M $ M Gross Profit $ $ $ Net Income / Loss $ $ -52.73M $ -67.99M Operating Income / Loss $ $ -54.04M $ -70.94M Cost of Revenue $ $ $ Net Cash Flow $ $ -18.84M $ M PE Ratio